Stocks

The table gives an overview of all stocks, alphabetically sorted.
 AALLON GROUP OYJ AALLON Mar 5, 2021 10.90 +0.93   
 Admicom Oyj ADMCM Mar 5, 2021 91.40 -3.38   
 Afarak Group AFAGR Mar 5, 2021 0.22 -1.33   
 Ahlstrom-Munksj÷ AM1 Mar 5, 2021 17.74 +0.11   
 Ahola Transport AHOLA Mar 5, 2021 1.65 +2.48   
 Aktia Bank AKTIA Mar 5, 2021 9.06 0.00   
 Alma Media ALMA Mar 5, 2021 9.50 +7.95   
 Altia ALTIA Mar 5, 2021 11.00 +0.18   
 Apetit APETIT Mar 5, 2021 12.30 +4.24   
 Aspo ASPO Mar 5, 2021 8.48 -1.17   
 Aspocomp Group ACG1V Mar 5, 2021 3.96 -1.25   
 Atria A ATRAV Mar 5, 2021 11.40 0.00   
 Basware BAS1V Mar 5, 2021 33.70 -2.88   
 BBS-Bioactive Bone Substitutes BONEH Mar 5, 2021 3.64 +2.82   
 Bilot Plc BILOT Mar 5, 2021 7.80 -7.14   
 Biohit B BIOBV Mar 5, 2021 2.06 -1.90   
 Bittium BITTI Mar 5, 2021 6.30 -3.23   
 Boreo Oyj BOREO Mar 5, 2021 32.40 +1.25   
 CapMan CAPMAN Mar 5, 2021 2.60 -0.19   
 Cargotec CGCBV Mar 5, 2021 42.78 -0.88   
 Caverion CAV1V Mar 5, 2021 5.23 +0.77   
 Citycon CTY1S Mar 5, 2021 7.55 -0.53   
 Componenta CTH1V Mar 5, 2021 2.99 -1.12   
 Consti Plc CONSTI Mar 5, 2021 12.70 -2.31   
 Detection Technology DETEC Mar 5, 2021 24.30 -4.33   
 Digia DIGIA Mar 5, 2021 7.26 0.00   
 Digitalist Group DIGIGR Mar 5, 2021 0.04 +7.33   
 Dovre Group DOV1V Mar 5, 2021 0.32 -2.77   
 EAB Group EAB Mar 5, 2021 3.28 0.00   
 Eezy Oyj EEZY Mar 5, 2021 5.12 -1.16   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK